Dany's BienenWohl

RSS

oxalic acid dihydrate

Authorised
This medicine is authorised for use in the European Union.

Overview

An overview of Dany’s BienenWohl and why it is authorised in the EU

Dany’s BienenWohl is a medicine used to treat varroosis in honey bee colonies. Varroosis is a disease of honey bees caused by infestation with a parasite called varroa mite (Varroa destructor). The varroa mite feeds on the haemolymph (blood) of adult bees and on brood (developing stages of the honey bee) resulting in harm and/or death of bees. The mite can also help spread viruses and bacteria. A significant mite infestation can lead to the collapse of a honey bee colony. Dany’s BienenWohl can only be used on colonies without brood and should be used as part of a wider management programme. If possible, the use of Dany’s BienenWohl should be alternated with another medicine that kills mites in a different way to reduce the chance of the mites developing resistance.

Dany’s BienenWohl contains the active substance oxalic acid. This medicine is the same as Oxybee, which is already authorised in the European Union (EU). The company that makes Oxybee has agreed that its scientific data can be used for Dany’s BienenWohl (‘informed consent’).

This EPAR was last updated on 17/07/2018

Authorisation details

Product details
Name
Dany's BienenWohl
Agency product number
EMEA/V/C/004667
Active substance
oxalic acid dihydrate
International non-proprietary name (INN) or common name
oxalic acid dihydrate
Species
Bees
Anatomical therapeutic chemical veterinary (ATCvet) codes
QP53AG03
Publication details
Marketing-authorisation holder
Dany Bienenwohl GmbH
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
14/06/2018
Contact address
Geyerspergerstrasse 27
80689 Munich
Germany

Product information

14/06/2018 Dany's BienenWohl - EMEA/V/C/004667 -

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Ectoparaciticides
  • insecticides and repellents

Therapeutic indication

For the treatment of varroosis (Varroa destructor) of honey bees (Apis mellifera) in brood free colonies.

Assessment history

How useful was this page?

Add your rating